195 related articles for article (PubMed ID: 38043008)
1. Correlation between IL3 signaling pathway-related genes and immune checkpoint inhibitor efficacy in patients with renal cell carcinoma.
Hou S; Gu T; Shi Y; Huang Y; Yao J; Luo P; Cao M; Zhang J; Lin A; Zhu W
Cancer Biomark; 2023; 38(4):489-504. PubMed ID: 38043008
[TBL] [Abstract][Full Text] [Related]
2. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
[TBL] [Abstract][Full Text] [Related]
3. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
Front Immunol; 2022; 13():954440. PubMed ID: 36059510
[TBL] [Abstract][Full Text] [Related]
4. A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy.
Lin J; Cai Y; Ma Y; Pan J; Wang Z; Zhang J; Liu Y; Zhao Z
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982415
[TBL] [Abstract][Full Text] [Related]
5. Using Genomic and Transcriptome Analyses to Identify the Role of the Oxidative Stress Pathway in Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance.
Che X; Qi X; Xu Y; Wang Q; Wu G
Oxid Med Cell Longev; 2021; 2021():5561124. PubMed ID: 34721758
[TBL] [Abstract][Full Text] [Related]
6. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.
Zheng A; Bai J; Ha Y; Yu Y; Fan Y; Liang M; Lu Y; Shen Z; Luo B; Jie W
BMC Cancer; 2023 Feb; 23(1):135. PubMed ID: 36759775
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
[TBL] [Abstract][Full Text] [Related]
9. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
Zhong S; Chen S; Lin H; Luo Y; He J
BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
[TBL] [Abstract][Full Text] [Related]
10. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
[TBL] [Abstract][Full Text] [Related]
11. Screening Novel Drug Candidates for Kidney Renal Clear Cell Carcinoma Treatment: A Study on Differentially Expressed Genes through the Connectivity Map Database.
Gao B; Wang L; Zhang N; Han M; Zhang Y; Liu H; Sun D; Liu Y
Kidney Blood Press Res; 2021; 46(6):702-713. PubMed ID: 34818247
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma.
Weng J; Huang Z; Li Q; Huang Y; Chen S
Int J Med Sci; 2023; 20(8):1046-1059. PubMed ID: 37484803
[No Abstract] [Full Text] [Related]
13. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
[No Abstract] [Full Text] [Related]
14. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
15. DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma.
Bao Y; Jiang A; Dong K; Gan X; Gong W; Wu Z; Liu B; Bao Y; Wang J; Wang L
Int J Biol Sci; 2021; 17(12):3158-3172. PubMed ID: 34421357
[TBL] [Abstract][Full Text] [Related]
16. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
Chen CC; Chu PY; Lin HY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
Chen X; Zhang Z; Qin Z; Zhu X; Wang K; Kang L; Li C; Wang H
Aging (Albany NY); 2024 Mar; 16(6):5676-5702. PubMed ID: 38517387
[TBL] [Abstract][Full Text] [Related]
18.
Klümper N; Ralser DJ; Bawden EG; Landsberg J; Zarbl R; Kristiansen G; Toma M; Ritter M; Hölzel M; Ellinger J; Dietrich D
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32234847
[TBL] [Abstract][Full Text] [Related]
19. Role of NF-κB pathway in kidney renal clear cell carcinoma and its potential therapeutic implications.
Sun J; Chen F; Wu G
Aging (Albany NY); 2023 Oct; 15(20):11313-11330. PubMed ID: 37847185
[TBL] [Abstract][Full Text] [Related]
20. Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing.
Sun J; Zhang X; Wu F; Zhu B; Xie H
BMC Urol; 2024 Apr; 24(1):84. PubMed ID: 38600527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
